市場調査レポート

商品コード

1766576

神経保護市場：製品タイプ別、作用機序別、用途別、患者属性別、性別、投与経路別、販売チャネル別、地域別

Neuroprotection Market, By Product Type, By Mechanism of Action, By Application, By Patient Demographics, By Gender, By Route of Administration, By Distribution Channel, By Geography

出版日: 2025年06月02日
発行: Coherent Market Insights
ページ情報: 英文 135 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 675,225円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,050,350円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,500,500円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=150.05円

全表示
概要
目次

概要

サンプル依頼リストに入れる

神経保護市場は、2025年には351億米ドルと推定され、2032年には578億5,000万米ドルに達すると予測され、2025年から2032年までの年間平均成長率（CAGR）は7.4%で成長する見込みです。

レポート範囲		レポート詳細
基準年	2024	2025年の市場規模	351億米ドル
実績データ	2020年から2024年まで	予測期間	2025年から2032年
予測期間：2025年～2032年CAGR：	7.40%	2032年の価値予測	578億5,000万米ドル

世界の神経保護市場は、さまざまな神経疾患や傷害による損傷から神経系を保護する治療戦略の開発と応用に重点を置き、ヘルスケア産業における重要な分野として浮上しています。神経保護には、神経細胞喪失の進行を予防または緩和することで認知機能を維持し、患者の予後を改善することを目的とした幅広いアプローチが含まれます。この市場は、アルツハイマー病、パーキンソン病、外傷性脳損傷、脳卒中などの神経疾患の有病率の増加により、研究者、製薬会社、ヘルスケアプロバイダーから大きな注目を集めています。高齢化が進み、これらの疾患の負担が増加する中、効果的な神経保護介入に対する需要が急増し、この分野での技術革新と投資が促進されています。

市場力学：

世界の神経保護市場の成長は、神経障害の有病率の増加、高齢化人口の増加、神経障害の予防における早期介入の重要性に対する意識の高まりなど、いくつかの主要な要因によって牽引されています。アルツハイマー病やパーキンソン病などの神経変性疾患の有病率は上昇傾向にあり、神経保護療法に対する大きな需要を生み出しています。さらに、事故やスポーツに関連した活動による外傷性脳損傷の発生率も市場の成長に寄与しています。しかし、市場には、薬剤開発コストの高さや、血液脳関門を越えて治療薬を送達することに伴う課題など、一定の抑制要因があります。

さらに、神経疾患の早期発見のための効果的な診断ツールがないことが、タイムリーな介入と治療の妨げとなっています。このような課題にもかかわらず、市場には成長と技術革新の大きな機会があります。個別化医療への注目の高まりと標的療法の開発は、神経保護に有望な道を提供します。ゲノミクス、プロテオミクス、バイオマーカー探索の開発により、新規創薬標的の同定と精密治療の開発に新たな可能性が生まれています。さらに、アカデミア、産業界、政府組織間の協力関係の深化は、研究開発努力を促進し、前臨床試験で得られた知見を臨床応用に結びつけることを加速しています。

本調査の主な特徴

本レポートでは、世界の神経保護市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模（10億米ドル）と年間平均成長率（CAGR%）を掲載しています。
また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の神経保護市場の主要企業をプロファイルしています。
本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
世界の神経保護市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
利害関係者は、世界の神経保護市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 35.10 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.40%	2032 Value Projection:	USD 57.85 Bn

The global neuroprotection market has emerged as a vital sector within the healthcare industry, focusing on the development and application of therapeutic strategies to safeguard the nervous system from damage caused by various neurological disorders and injuries. Neuroprotection encompasses a wide range of approaches aimed at preventing or mitigating the progression of neuronal loss, thereby preserving cognitive function and improving patient outcomes. This market has garnered significant attention from researchers, pharmaceutical companies, and healthcare providers due to the increasing prevalence of neurological conditions such as Alzheimer's disease, Parkinson's disease, traumatic brain injury, and stroke. With the growing aging population and the rising burden of these disorders, the demand for effective neuroprotective interventions has surged, driving innovation and investment in this field.

Market Dynamics:

The global neuroprotection market growth is driven by several key factors, including the increasing prevalence of neurological disorders, growing aging population, and rising awareness about the importance of early intervention in preventing neurological damage. The prevalence of neurodegenerative diseases such as Alzheimer's and Parkinson's has been on the rise, creating a significant demand for neuroprotective therapies. Additionally, the incidence of traumatic brain injuries due to accidents and sports-related activities has also contributed to the market growth. However, the market faces certain restraints, such as the high cost of drug development and the challenges associated with delivering therapeutics across the blood-brain barrier.

Moreover, the lack of effective diagnostic tools for early detection of neurological disorders hinders timely intervention and treatment. Despite these challenges, the market presents substantial opportunities for growth and innovation. The increasing focus on personalized medicine and the development of targeted therapies offer promising avenues for neuroprotection. Advancements in genomics, proteomics, and biomarker discovery have opened up new possibilities for identifying novel drug targets and developing precision therapies. Furthermore, the growing collaboration between academia, industry, and government organizations has fostered research and development efforts, accelerating the translation of preclinical findings into clinical applications.

Key features of the study:

This report provides an in-depth analysis of the global neuroprotection market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global neuroprotection market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Biogen Inc., Amgen Inc., Novartis AG, Eli Lilly and Company, Roche Holding AG, Pfizer Inc., Sanofi S.A., Merck & Co., Inc., AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Johnson & Johnson, AbbVie Inc., GSK (GlaxoSmithKline), Takeda Pharmaceutical Company Limited, and UCB S.A.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global neuroprotection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuroprotection market

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Pharmaceuticals
- Biologics
- Nutraceuticals
- Others
Mechanism Of Action Insights (Revenue, USD Bn, 2020 - 2032)
- Antioxidants
- Anti-inflammatory Drugs
- Neurotransmitter Modulators
- Calcium Channel Blockers
- NMDA Receptor Antagonists
- Others
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Alzheimer's Disease
- Parkinson's Disease
- Multiple Sclerosis
- Amyotrophic Lateral Sclerosis (ALS)
- Huntington's Disease
- Traumatic Brain Injury (TBI)
- Ischemic Stroke
- Epilepsy
- Retinal Degeneration
- Glaucoma
- Spinal Cord Injuries
- Others
Patient Demographics Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric Patients
- Adult Patients
- Geriatric Patients
Gender Insights (Revenue, USD Bn, 2020 - 2032)
- Male
- Female
Route Of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Oral
- Injectable
- Intranasal
- Transdermal
- Sublingual
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Biogen Inc.
- Amgen Inc.
- Novartis AG
- Eli Lilly and Company
- Roche Holding AG
- Pfizer Inc.
- Sanofi S.A.
- Merck & Co., Inc.
- AstraZeneca PLC
- Teva Pharmaceutical Industries Ltd.
- Johnson & Johnson
- AbbVie Inc.
- GSK (GlaxoSmithKline)
- Takeda Pharmaceutical Company Limited
- UCB S.A.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Neuroprotection Market, By Product Type
- Global Neuroprotection Market, By Mechanism of Action
- Global Neuroprotection Market, By Application
- Global Neuroprotection Market, By Patient Demographics
- Global Neuroprotection Market, By Gender
- Global Neuroprotection Market, By Route of Administration
- Global Neuroprotection Market, By Distribution Channel
- Global Neuroprotection Market, By Region

3. Market Dynamics, Regulations, And Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Neuroprotection Market, By Product Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pharmaceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Nutraceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Neuroprotection Market, By Mechanism of Action, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Antioxidants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Anti-inflammatory Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurotransmitter Modulators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Calcium Channel Blockers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
NMDA Receptor Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Neuroprotection Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Alzheimer's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Parkinson's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Multiple Sclerosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Amyotrophic Lateral Sclerosis (ALS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Huntington's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Traumatic Brain Injury (TBI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ischemic Stroke
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Epilepsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retinal Degeneration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Glaucoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Spinal Cord Injuries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Neuroprotection Market, By Patient Demographics, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Adult Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Geriatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Neuroprotection Market, By Gender, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Neuroprotection Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intranasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Transdermal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sublingual
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Neuroprotection Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Neuroprotection Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

12. Competitive Landscape

Biogen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GSK (GlaxoSmithKline)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
UCB S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

13. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

14. References and Research Methodology

References
Research Methodology
About us

神経保護市場：製品タイプ別、作用機序別、用途別、患者属性別、性別、投与経路別、販売チャネル別、地域別

Neuroprotection Market, By Product Type, By Mechanism of Action, By Application, By Patient Demographics, By Gender, By Route of Administration, By Distribution Channel, By Geography

市場力学：

本調査の主な特徴

目次

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の神経保護市場、製品タイプ別、2020年～2032年

第5章世界の神経保護市場、作用機序別、2020年～2032年

第6章世界の神経保護市場、用途別、2020年～2032年

第7章世界の神経保護市場、患者属性別、2020年～2032年

第8章世界の神経保護市場、性別、2020年～2032年

第9章世界の神経保護市場、投与経路別、2020年～2032年

第10章世界の神経保護市場、流通チャネル別、2020年～2032年

第11章世界の神経保護市場、地域別、2020年～2032年

第12章競合情勢

第13章アナリストの推奨事項

第14章参考文献と調査手法

Market Dynamics:

Key features of the study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, And Trends Analysis

4. Global Neuroprotection Market, By Product Type, 2020-2032, (USD Bn)

5. Global Neuroprotection Market, By Mechanism of Action, 2020-2032, (USD Bn)

6. Global Neuroprotection Market, By Application, 2020-2032, (USD Bn)

7. Global Neuroprotection Market, By Patient Demographics, 2020-2032, (USD Bn)

8. Global Neuroprotection Market, By Gender, 2020-2032, (USD Bn)

9. Global Neuroprotection Market, By Route of Administration, 2020-2032, (USD Bn)

10. Global Neuroprotection Market, By Distribution Channel, 2020-2032, (USD Bn)

11. Global Neuroprotection Market, By Region, 2020 - 2032, Value (USD Bn)

12. Competitive Landscape

13. Analyst Recommendations

14. References and Research Methodology

神経保護市場：製品タイプ別、作用機序別、用途別、患者属性別、性別、投与経路別、販売チャネル別、地域別

Neuroprotection Market, By Product Type, By Mechanism of Action, By Application, By Patient Demographics, By Gender, By Route of Administration, By Distribution Channel, By Geography

市場力学：

本調査の主な特徴

目次

第1章 調査の目的と前提条件

第2章 市場の展望

第3章 市場力学、規制、動向分析

第4章 世界の神経保護市場、製品タイプ別、2020年～2032年

第5章 世界の神経保護市場、作用機序別、2020年～2032年

第6章 世界の神経保護市場、用途別、2020年～2032年

第7章 世界の神経保護市場、患者属性別、2020年～2032年

第8章 世界の神経保護市場、性別、2020年～2032年

第9章 世界の神経保護市場、投与経路別、2020年～2032年

第10章 世界の神経保護市場、流通チャネル別、2020年～2032年

第11章 世界の神経保護市場、地域別、2020年～2032年

第12章 競合情勢

第13章 アナリストの推奨事項

第14章 参考文献と調査手法

Market Dynamics:

Key features of the study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, And Trends Analysis

4. Global Neuroprotection Market, By Product Type, 2020-2032, (USD Bn)

5. Global Neuroprotection Market, By Mechanism of Action, 2020-2032, (USD Bn)

6. Global Neuroprotection Market, By Application, 2020-2032, (USD Bn)

7. Global Neuroprotection Market, By Patient Demographics, 2020-2032, (USD Bn)

8. Global Neuroprotection Market, By Gender, 2020-2032, (USD Bn)

9. Global Neuroprotection Market, By Route of Administration, 2020-2032, (USD Bn)

10. Global Neuroprotection Market, By Distribution Channel, 2020-2032, (USD Bn)

11. Global Neuroprotection Market, By Region, 2020 - 2032, Value (USD Bn)

12. Competitive Landscape

13. Analyst Recommendations

14. References and Research Methodology

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の神経保護市場、製品タイプ別、2020年～2032年

第5章世界の神経保護市場、作用機序別、2020年～2032年

第6章世界の神経保護市場、用途別、2020年～2032年

第7章世界の神経保護市場、患者属性別、2020年～2032年

第8章世界の神経保護市場、性別、2020年～2032年

第9章世界の神経保護市場、投与経路別、2020年～2032年

第10章世界の神経保護市場、流通チャネル別、2020年～2032年

第11章世界の神経保護市場、地域別、2020年～2032年

第12章競合情勢

第13章アナリストの推奨事項

第14章参考文献と調査手法